Recent decades have seen health expenditures increase much faster in the United States than in other countries1 even as the United States has made far less progress in improving life expectancy.2 While many of the most significant medical breakthroughs in the world have been developed in this country, and while the United States ranks first in health care spending worldwide,1 it ranks 26th in life expectancy.2 Given the gap between what the United States spends and the health of the US population, it is striking that efforts to develop new medical technologies, often at considerable expense, so consistently outpace the efforts to deploy the ones that we already have.
Volpp KG, Krumholz HM, Asch DA. Mass Customization for Population Health. JAMA Cardiol. 2018;3(5):363–364. doi:10.1001/jamacardio.2017.5353
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: